More FDA Legislation News
Recent Posts
- FDA Legislative Watch Special Update
- U.S. FDA Inspections in China
- Digital Mammography Firms Decry Clinical Trial Provisions In Draft Guidance
- Medicare Bundling Provisions Could Boost Affymax ESA in ESRD Arena
- FDA List Of Potential Safety Signals Has 3 Pfizer Drugs, Echoes Drug Watch Site
- Sweeping Changes In India’s Clinical Trial Laws Could Allow Phase I MNC Studies Under Certain Circumstances
- Physician Payment Disclosure Bill Should Include Other Entities – MedPAC
- Pregnancy Registries Should Not Be Mandated In Drug Label, Amgen Tells FDA
- Marketing Oversight By States Creates Multiple Compliance Standards For Firms
- New Generics Need To Influence Medicare Rates More Quickly – OIG
Useful Links
- BioHealth Investor
- BioPharma Today
- Compliance-Alliance
- Drug Discovery Today
- EuroPharma Today
- Eye On FDA
- FDA Law Blog
- FDA Legislative Watch
- IN VIVO
- IN VIVO Blog
- Inteleos
- Medical Device Manufacturers Association
- Medical Devices Today
- Medtech Insight
- Over The Counter Today
- PharmAsia News
- RPM REPORT
- Search Company Profiles
- Spicy IP Blog (India)
- Start-Up
Notices
- Copyright©2008-2009, F-D-C Reports, Inc. and Windhover Information Inc. All rights reserved.
Search FDA Legislative Watch
- Search FLW
